• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/1/21 4:49:30 PM ET
    $JWS
    Business Services
    Finance
    Get the next $JWS alert in real time by email
    SC 13G 1 tm214886d2_sc13g.htm SCHEDULE 13G

     

     

     

     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C.  20549
     
    SCHEDULE 13G*/
    (Rule 13d-102)
     
    Jaws Acquisition Corp.
      (Name of Issuer)
     
    Class A ordinary shares, par value $0.0001 per share
    (Title of Class of Securities)

     

    G50744104**

    (CUSIP Number)

     

    January 21, 2021

    Date of Event Which Requires Filing of the Statement

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1(b)
    x Rule 13d-1(c)
    ¨ Rule 13d-1(d)

     

     

    */ The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    ** (See item 2(e))

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

     

     

    CUSIP No. G50744104 13G Page 2 of 14 Pages

     

     

    1.

     

    NAME OF REPORTING PERSON

     

     

    Citadel Advisors LLC

     

    2.

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)       ¨

    (b)       ¨

     

    3.

     

    SEC USE ONLY

     

     

    4.

     

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

     

    5.

     

    SOLE VOTING POWER

    0

     

    6.

     

    SHARED VOTING POWER

     

    5,167,446 shares

     

     

    7.

     

    SOLE DISPOSITIVE POWER

    0

     

    8.

     

     

    SHARED DISPOSITIVE POWER

    See Row 6 above

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    See Row 6 above

     

    10.

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                                                          ¨

     

    11.

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    7.5%1

     

     

     

    12.

     

     

    TYPE OF REPORTING PERSON

    IA; OO; HC

     

           

    1The percentages reported in this Schedule 13G are based upon 69,000,000 Class A ordinary shares outstanding as of November 10, 2020 (according to the issuer’s Form 10-Q as filed with the Securities and Exchange Commission on November 10, 2020). Except as described in the preceding sentence, all share numbers for the holdings of the reporting persons reported in this Schedule 13G are as of the opening of the market on February 1, 2021.

     

     

     

     

    CUSIP No. G50744104 13G Page 3 of 14 Pages

     

     

    1.

     

    NAME OF REPORTING PERSON

     

     

    Citadel Advisors Holdings LP

     

    2.

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)       ¨

    (b)       ¨

     

    3.

     

    SEC USE ONLY

     

     

    4.

     

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

     

    5.

     

    SOLE VOTING POWER

    0

     

    6.

     

    SHARED VOTING POWER

     

    5,167,446 shares

     

     

    7.

     

    SOLE DISPOSITIVE POWER

    0

     

    8.

     

     

    SHARED DISPOSITIVE POWER

    See Row 6 above

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    See Row 6 above

     

    10.

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                                                          ¨

     

    11.

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    7.5%

     

     

     

    12.

     

     

    TYPE OF REPORTING PERSON

    PN; HC

     

           

     

     

     

     

    CUSIP No. G50744104 13G Page 4 of 14 Pages

     

     

    1.

     

    NAME OF REPORTING PERSON

     

     

    Citadel GP LLC

     

    2.

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)       ¨

    (b)       ¨

     

    3.

     

    SEC USE ONLY

     

     

    4.

     

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

     

    5.

     

    SOLE VOTING POWER

    0

     

    6.

     

    SHARED VOTING POWER

     

    5,167,446 shares

     

     

    7.

     

    SOLE DISPOSITIVE POWER

    0

     

    8.

     

     

    SHARED DISPOSITIVE POWER

    See Row 6 above.

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    See Row 6 above.

     

    10.

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                                                          ¨

     

    11.

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    7.5%

     

     

     

    12.

     

     

    TYPE OF REPORTING PERSON

    OO; HC

     

           

     

     

     

    CUSIP No. G50744104 13G Page 5 of 14 Pages

     

     

    1.

     

    NAME OF REPORTING PERSON

     

     

    Citadel Securities LLC

     

    2.

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)       ¨

    (b)       ¨

     

    3.

     

    SEC USE ONLY

     

     

    4.

     

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

     

    5.

     

    SOLE VOTING POWER

    0

     

    6.

     

    SHARED VOTING POWER

     

    32,299 shares

     

     

    7.

     

    SOLE DISPOSITIVE POWER

    0

     

    8.

     

     

    SHARED DISPOSITIVE POWER

    See Row 6 above.

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    See Row 6 above.

     

    10.

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                                                          ¨

     

    11.

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    Less than 0.1%

     

     

     

    12.

     

     

    TYPE OF REPORTING PERSON

    BD, OO

     

           

     

     

     

     

    CUSIP No. G50744104 13G Page 6 of 14 Pages

     

     

    1.

     

    NAME OF REPORTING PERSON

     

     

    CALC IV LP

     

    2.

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)       ¨

    (b)       ¨

     

    3.

     

    SEC USE ONLY

     

     

    4.

     

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

     

    5.

     

    SOLE VOTING POWER

    0

     

    6.

     

    SHARED VOTING POWER

     

    32,299 shares

     

     

    7.

     

    SOLE DISPOSITIVE POWER

    0

     

    8.

     

     

    SHARED DISPOSITIVE POWER

    See Row 6 above.

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    See Row 6 above.

     

    10.

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                                                          ¨

     

    11.

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    Less than 0.1%

     

     

     

    12.

     

     

    TYPE OF REPORTING PERSON

    PN; HC

     

           

     

     

     

     

    CUSIP No. G50744104 13G Page 7 of 14 Pages

     

     

    1.

     

    NAME OF REPORTING PERSON

     

     

    Citadel Securities GP LLC

     

    2.

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)       ¨

    (b)       ¨

     

    3.

     

    SEC USE ONLY

     

     

    4.

     

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

     

    5.

     

    SOLE VOTING POWER

    0

     

    6.

     

    SHARED VOTING POWER

     

    32,299 shares

     

     

    7.

     

    SOLE DISPOSITIVE POWER

    0

     

    8.

     

     

    SHARED DISPOSITIVE POWER

    See Row 6 above.

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    See Row 6 above.

     

    10.

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                                                          ¨

     

    11.

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    Less than 0.1%

     

     

     

    12.

     

     

    TYPE OF REPORTING PERSON

    OO; HC

     

           

     

     

     

     

    CUSIP No. G50744104 13G Page 8 of 14 Pages

     

     

    1.

     

    NAME OF REPORTING PERSON

     

     

    Kenneth Griffin

     

    2.

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)       ¨

    (b)       ¨

     

    3.

     

    SEC USE ONLY

     

     

    4.

     

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

    U.S. Citizen

     

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

     

    5.

     

    SOLE VOTING POWER

    0

     

    6.

     

    SHARED VOTING POWER

     

    5,199,745 shares

     

     

    7.

     

    SOLE DISPOSITIVE POWER

    0

     

    8.

     

     

    SHARED DISPOSITIVE POWER

    See Row 6 above

     

    9.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    See Row 6 above

     

    10.

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES                                                                          ¨

     

    11.

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    7.5%

     

     

     

    12.

     

     

    TYPE OF REPORTING PERSON

    IN; HC

     

           

     

     

     

     

    CUSIP No. G50744104 13G Page 9 of 14 Pages

     

    Item 1(a)Name of Issuer

    Jaws Acquisition Corp.

     

    Item 1(b) Address of Issuer’s Principal Executive Offices
    1601 Washington Avenue, Suite 800, Miami Beach, FL

     

    Item 2(a)Name of Person Filing
    This Schedule 13G is being jointly filed by Citadel Advisors LLC (“Citadel Advisors”), Citadel Advisors Holdings LP (“CAH”), Citadel GP LLC (“CGP”), Citadel Securities LLC (“Citadel Securities”), CALC IV LP (“CALC4”), Citadel Securities GP LLC (“CSGP”) and Mr. Kenneth Griffin (collectively with Citadel Advisors, CAH, CGP, Citadel Securities, CALC4 and CSGP, the “Reporting Persons”) with respect to Class A ordinary shares (and options to purchase Class A ordinary shares) of the above-named issuer owned by Citadel Multi-Strategy Equities Master Fund Ltd., a Cayman Islands company (“CM”), and Citadel Securities.

     

    Citadel Advisors is the portfolio manager for CM. CAH is the sole member of Citadel Advisors. CGP is the general partner of CAH. CALC4 is the non-member manager of Citadel Securities. CSGP is the general partner of CALC4. Mr. Griffin is the President and Chief Executive Officer of CGP, and owns a controlling interest in CGP and CSGP.

     

    The filing of this statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement other than the securities actually owned by such person (if any).

     

    Item 2(b)Address of Principal Business Office
    The address of the principal business office of each of the Reporting Persons is 131 S. Dearborn Street, 32nd Floor, Chicago, Illinois 60603.

     

    Item 2(c)Citizenship
    Each of Citadel Advisors, CGP, Citadel Securities and CSGP is organized as a limited liability company under the laws of the State of Delaware. Each of CALC4 and CAH is organized as a limited partnership under the laws of the State of Delaware. Mr. Griffin is a U.S. citizen.

     

    Item 2(d) Title of Class of Securities
    Class A ordinary shares, par value $0.0001 per share

     

    Item 2(e)CUSIP Number
    As of the date of this Schedule 13G, a CUSIP number for the issuer’s Class A ordinary shares stock is not available. Initially, each of Class A ordinary shares and warrants to purchase Class A ordinary shares will trade as a unit. The CUSIP number for the issuer’s units is G50744104.

     

     

     

     

    CUSIP No. G50744104 13G Page 10 of 14 Pages

     

    Item 3If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     

    (a)¨ Broker or dealer registered under Section 15 of the Exchange Act;

     

    (b)¨ Bank as defined in Section 3(a)(6) of the Exchange Act;

     

    (c)¨ Insurance company as defined in Section 3(a)(19) of the Exchange Act;

     

    (d)¨ Investment company registered under Section 8 of the Investment Company Act;

     

    (e)¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     

    (f)¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

     

    (g)¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

     

    (h)¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

     

    (i)¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;

     

    (j)¨ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);

     

    (k)¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution:                              .

     

     

     

     

    CUSIP No. G50744104 13G Page 11 of 14 Pages

     

    Item 4 Ownership

     

    A.Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC

     

    (a)Each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC may be deemed to beneficially own 5,167,446 Class A ordinary shares.

     

    (b)The number of shares each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC may be deemed to beneficially own constitutes approximately 7.5% of the Class A ordinary shares outstanding.

     

    (c)Number of shares as to which such person has:

     

    (i)sole power to vote or to direct the vote: 0

     

    (ii)shared power to vote or to direct the vote: 5,167,446

     

    (iii)sole power to dispose or to direct the disposition of: 0

     

    (iv)shared power to dispose or to direct the disposition of: 5,167,446

     

    B.Citadel Securities LLC

     

    (a)Citadel Securities LLC may be deemed to beneficially own 32,299 Class A ordinary shares.

     

    (b)The number of shares that Citadel Securities LLC may be deemed to beneficially own constitutes less than 0.1% of the Class A ordinary shares outstanding.

     

    (c)Number of shares as to which such person has:

     

    (i)sole power to vote or to direct the vote: 0

     

    (ii)shared power to vote or to direct the vote: 32,299

     

    (iii)sole power to dispose or to direct the disposition of: 0

     

    (iv)shared power to dispose or to direct the disposition of: 32,299

     

    C.CALC IV LP and Citadel Securities GP LLC

     

    (a)Each of CALC IV LP and Citadel Securities GP LLC may be deemed to beneficially own 32,299 Class A ordinary shares.

     

    (b)The number of shares that each of CALC IV LP and Citadel Securities GP LLC may be deemed to beneficially own constitutes less than 0.1% of the Class A ordinary shares outstanding.

     

     

     

     

    CUSIP No. G50744104 13G Page 12 of 14 Pages

     

    (c)Number of shares as to which such person has:

     

    (i)sole power to vote or to direct the vote: 0

     

    (ii)shared power to vote or to direct the vote: 32,299

     

    (iii)sole power to dispose or to direct the disposition of: 0

     

    (iv)shared power to dispose or to direct the disposition of: 32,299

     

    D.Kenneth Griffin

     

    (a)Mr. Griffin may be deemed to beneficially own 5,199,745 Class A ordinary shares.

     

    (b)The number of shares that Mr. Griffin may be deemed to beneficially own constitutes approximately 7.5% of the Class A ordinary shares outstanding.

     

    (c)Number of shares as to which such person has:

     

    (i)sole power to vote or to direct the vote: 0

     

    (ii)shared power to vote or to direct the vote: 5,199,745

     

    (iii)sole power to dispose or to direct the disposition of: 0

     

    (iv)shared power to dispose or to direct the disposition of: 5,199,745

     

     

     

     

     

    CUSIP No. G50744104 13G Page 13 of 14 Pages

     

    Item 5Ownership of Five Percent or Less of a Class
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ¨.

     

    Item 6Ownership of More than Five Percent on Behalf of Another Person

    Not Applicable

     

    Item 7Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company

    See Item 2 above

     

    Item 8Identification and Classification of Members of the Group

    Not Applicable

     

    Item 9Notice of Dissolution of Group

    Not Applicable

     

    Item 10Certification
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     

    CUSIP No. G50744104 13G Page 14 of 14 Pages

     

     

    After reasonable inquiry and to the best of its knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

     

    Dated this 1st day of February, 2021.

     

    CITADEL SECURITIES LLC   CITADEL ADVISORS LLC
         
    By: /s/ Guy Miller   By: /s/ Gregory Johnson
      Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory
         
    CALC IV LP   CITADEL ADVISORS HOLDINGS LP
         
    By: /s/ Guy Miller   By: /s/ Gregory Johnson
      Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory
         
    CITADEL SECURITIES GP LLC   CITADEL GP LLC
         
    By: /s/ Guy Miller   By: /s/ Gregory Johnson
      Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory
         
        KENNETH GRIFFIN
         
        By: /s/ Gregory Johnson
          Gregory Johnson, attorney-in-fact*

     

     

    *Gregory Johnson is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney filed with the Securities and Exchange Commission herewith as Exhibit 24.

     

     

     

     

     

    Get the next $JWS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $JWS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $JWS
    SEC Filings

    View All

    SEC Form 8-K filed by Jaws Acquisition Corp.

    8-K - Cano Health, Inc. (0001800682) (Filer)

    7/6/21 6:42:14 AM ET
    $JWS
    Business Services
    Finance

    SEC Form S-1 filed by Jaws Acquisition Corp.

    S-1 - Cano Health, Inc. (0001800682) (Filer)

    6/25/21 5:28:55 PM ET
    $JWS
    Business Services
    Finance

    Jaws Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Cano Health, Inc. (0001800682) (Filer)

    6/14/21 6:30:29 AM ET
    $JWS
    Business Services
    Finance

    $JWS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by Morales Angel L

    3 - Cano Health, Inc. (0001800682) (Issuer)

    6/23/21 3:06:35 PM ET
    $JWS
    Business Services
    Finance

    SEC Form 3 filed by TRUJILLO SOLOMON D

    3 - Cano Health, Inc. (0001800682) (Issuer)

    6/15/21 7:12:01 PM ET
    $JWS
    Business Services
    Finance

    SEC Form 3 filed by Gold Lewis

    3 - Cano Health, Inc. (0001800682) (Issuer)

    6/15/21 6:44:37 PM ET
    $JWS
    Business Services
    Finance

    $JWS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cano Health Closes Business Combination with Jaws Acquisition Corp. and Will Begin Trading on the New York Stock Exchange

    MIAMI, June 3, 2021 /PRNewswire/ -- Cano Health, Inc. ("Cano Health," the "Company," "we," "our" or "us"), a leading value-based primary care provider for seniors and underserved communities, today announced it has completed its business combination with Jaws Acquisition Corp. ("Jaws") (NYSE: JWS). The business combination, which was approved by Jaws' stockholders at its special meeting held on June 2, 2021, will enable Cano Health to achieve its vision of becoming America's leader in primary care and accelerate the Company's growth. Beginning June 4, 2021, Cano Health's shares of Class A common stock will trade on the New York Stock Exchange ("NYSE") under the symbol "CANO." "This is an imp

    6/3/21 4:10:00 PM ET
    $JWS
    Business Services
    Finance

    Jaws Acquisition Corp. Announces Extraordinary General Meeting Teleconference Details

    MIAMI, May 24, 2021 /PRNewswire/ -- Jaws Acquisition Corp. ("Jaws") (NYSE:JWS), today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders from federal and New York authorities, it is strongly encouraging that shareholders attend the extraordinary general meeting of its shareholders, which will be held on June 2, 2021 at 9:00 a.m., New York City Time (the "General Meeting"), by teleconference rather than in person. The purpose of the General Meeting is to vote on certain proposals relating to the previously announced merger between Jaws and Cano Health, LLC ("Cano Health" or the "Company"), the related Busi

    5/24/21 8:00:00 AM ET
    $JWS
    Business Services
    Finance

    Jaws Acquisition Corp. Announces Effectiveness of Registration Statement and Sets Special Meeting Date for Proposed Business Combination with Cano Health

    MIAMI, May 10, 2021 /PRNewswire/ -- Jaws Acquisition Corp. (NYSE:JWS), a special purpose acquisition company ("Jaws"), announced today the effectiveness of its Registration Statement, in connection with its previously announced merger with Cano Health, LLC ("Cano Health"), on Form S-4, with the United States Securities and Exchange Commission (the "SEC"). Jaws also announced a special meeting of its shareholders (the "Special Meeting") to approve the proposed merger agreement with Cano Health for June 2, 2021 at 9:00 a.m., Eastern Time, unless postponed or adjourned to a later date or time. Jaws will distribute the definitive proxy statement and proxy card to its stockholders of record as of

    5/10/21 8:00:00 AM ET
    $JWS
    Business Services
    Finance

    $JWS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Jaws Acquisition Corp.

    SC 13D - Cano Health, Inc. (0001800682) (Subject)

    6/14/21 5:21:02 PM ET
    $JWS
    Business Services
    Finance

    SEC Form SC 13G filed by Jaws Acquisition Corp.

    SC 13G - Jaws Acquisition Corp. (0001800682) (Subject)

    4/5/21 8:30:35 AM ET
    $JWS
    Business Services
    Finance

    SEC Form SC 13G/A filed

    SC 13G/A - Jaws Acquisition Corp. (0001800682) (Subject)

    2/16/21 3:06:07 PM ET
    $JWS
    Business Services
    Finance